U.S. Markets close in 4 hrs 27 mins

Synthetic Biologics, Inc. (SYN)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.5105-0.0084 (-1.62%)
As of 11:30AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5189
Open0.5020
Bid0.5100 x 800
Ask0.5083 x 800
Day's Range0.5012 - 0.5282
52 Week Range0.2500 - 1.7000
Volume854,456
Avg. Volume17,679,276
Market Cap66.189M
Beta (5Y Monthly)1.93
PE Ratio (TTM)N/A
EPS (TTM)-0.6600
Earnings DateMay 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.88
  • Synthetic Biologics Reports 2021 First Quarter Operational Highlights and Financial Results
    PR Newswire

    Synthetic Biologics Reports 2021 First Quarter Operational Highlights and Financial Results

    Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, today provided a clinical programs update and reported financial results for the quarter ended March 31, 2021.

  • ACCESSWIRE

    Synthetic Biologics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Synthetic Biologics, Inc. (AMEX:SYN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.

  • Synthetic Biologics to Report 2021 First Quarter Operational Highlights and Financial Results on May 5, 2021
    PR Newswire

    Synthetic Biologics to Report 2021 First Quarter Operational Highlights and Financial Results on May 5, 2021

    Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced today that the Company intends to release its operational highlights and financial results for the quarter ended March 31, 2021 on Wednesday, May 5, 2021, and to host a conference call the same day at 4:30 p.m. ET. The dial-in information for the call is as follows: